Heat-shock protein-peptide complex-96 for the treatment of cancer (Q36909395)

17 August 2017

1 reference

title

Heat-shock protein-peptide complex-96 for the treatment of cancer (English)

1 reference

17 August 2017

Robert J Amato

1

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Expert Opinion on Biological Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

8

1 reference

17 August 2017

page(s)

1267-1273

1 reference

Principles and use of anti-CTLA4 antibody in human cancer immunotherapy

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

A new puffing pattern induced by temperature shock and DNP in drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Immunotherapy for human cancer using heat shock protein-peptide complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Structural analysis of substrate binding by the molecular chaperone DnaK

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Identification of the peptide-binding site in the heat shock chaperone/tumor rejection antigen gp96 (Grp94).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

GRP94 (gp96) and GRP94 N-terminal geldanamycin binding domain elicit tissue nonrestricted tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Identification of the N-terminal peptide binding site of glucose-regulated protein 94.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

The Hsp90 chaperone complex as a novel target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Immunization with gp96 from Listeria monocytogenes-infected mice is due to N-formylated listerial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Proteomics shows Hsp70 does not bind peptide sequences indiscriminately in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Testing the role of gp96 as peptide chaperone in antigen processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Heat shock protein--peptide complexes as immunotherapy for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Roles of heat-shock proteins in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Essential role of CD91 in re-presentation of gp96-chaperoned peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Chaperoning function of stress protein grp170, a member of the hsp70 superfamily, is responsible for its immunoadjuvant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Evaluation of renal cell carcinoma vaccines targeting carbonic anhydrase IX using heat shock protein 110.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

DNA vaccination with gp96-peptide fusion proteins induces protection against an intracellular bacterial pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Heat shock proteins and their use as anticancer vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.8.1267

10.1517/14712598.7.8.1267

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference